Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase

Here the authors combine next generation sequencing on plasma from participants of the ADVANCE clinical trial with virological and follow-up data to investigate the impact of pre-treatment drug resistance (PDR) to non-nucleoside reverse transcriptase inhibitors (NNRTIs) on the efficacy of second-gen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mark J. Siedner, Michelle A. Moorhouse, Bryony Simmons, Tulio de Oliveira, Richard Lessells, Jennifer Giandhari, Stephen A. Kemp, Benjamin Chimukangara, Godspower Akpomiemie, Celicia M. Serenata, Willem D. F. Venter, Andrew Hill, Ravindra K. Gupta
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/1698782bd5904ceaa2191d4ec77b5aff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1698782bd5904ceaa2191d4ec77b5aff
record_format dspace
spelling oai:doaj.org-article:1698782bd5904ceaa2191d4ec77b5aff2021-12-02T15:39:13ZReduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase10.1038/s41467-020-19801-x2041-1723https://doaj.org/article/1698782bd5904ceaa2191d4ec77b5aff2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-19801-xhttps://doaj.org/toc/2041-1723Here the authors combine next generation sequencing on plasma from participants of the ADVANCE clinical trial with virological and follow-up data to investigate the impact of pre-treatment drug resistance (PDR) to non-nucleoside reverse transcriptase inhibitors (NNRTIs) on the efficacy of second-generation integrase inhibitors and find an association between NNRTI resistance prior to treatment and long-term treatment.Mark J. SiednerMichelle A. MoorhouseBryony SimmonsTulio de OliveiraRichard LessellsJennifer GiandhariStephen A. KempBenjamin ChimukangaraGodspower AkpomiemieCelicia M. SerenataWillem D. F. VenterAndrew HillRavindra K. GuptaNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Mark J. Siedner
Michelle A. Moorhouse
Bryony Simmons
Tulio de Oliveira
Richard Lessells
Jennifer Giandhari
Stephen A. Kemp
Benjamin Chimukangara
Godspower Akpomiemie
Celicia M. Serenata
Willem D. F. Venter
Andrew Hill
Ravindra K. Gupta
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
description Here the authors combine next generation sequencing on plasma from participants of the ADVANCE clinical trial with virological and follow-up data to investigate the impact of pre-treatment drug resistance (PDR) to non-nucleoside reverse transcriptase inhibitors (NNRTIs) on the efficacy of second-generation integrase inhibitors and find an association between NNRTI resistance prior to treatment and long-term treatment.
format article
author Mark J. Siedner
Michelle A. Moorhouse
Bryony Simmons
Tulio de Oliveira
Richard Lessells
Jennifer Giandhari
Stephen A. Kemp
Benjamin Chimukangara
Godspower Akpomiemie
Celicia M. Serenata
Willem D. F. Venter
Andrew Hill
Ravindra K. Gupta
author_facet Mark J. Siedner
Michelle A. Moorhouse
Bryony Simmons
Tulio de Oliveira
Richard Lessells
Jennifer Giandhari
Stephen A. Kemp
Benjamin Chimukangara
Godspower Akpomiemie
Celicia M. Serenata
Willem D. F. Venter
Andrew Hill
Ravindra K. Gupta
author_sort Mark J. Siedner
title Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
title_short Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
title_full Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
title_fullStr Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
title_full_unstemmed Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
title_sort reduced efficacy of hiv-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/1698782bd5904ceaa2191d4ec77b5aff
work_keys_str_mv AT markjsiedner reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT michelleamoorhouse reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT bryonysimmons reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT tuliodeoliveira reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT richardlessells reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT jennifergiandhari reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT stephenakemp reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT benjaminchimukangara reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT godspowerakpomiemie reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT celiciamserenata reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT willemdfventer reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT andrewhill reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
AT ravindrakgupta reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase
_version_ 1718385915526643712